Create Account
Sign In
Dark
chart
exchange
Terminal
Screener
Stocks
Crypto
Forex
Watchlists
Trends

CANF
Can-Fite Biopharma Ltd - ADR
stock NYSEAMERICAN ADR

Market Open
5/30/2023 12:35:30 PM EDT
2.43USD+8.482%(+0.19)0
1.93Bid   2.98Ask   1.05Spread IEX
Pre-market
5/30/2023 8:00:30 AM EDT
2.50USD+11.607%(+0.26)0
After-hours
5/2/2023 4:03:30 PM EDT
2.01USD+0.500%(+0.01)0
OverviewHistoricalExchange VolumeShort VolumeBorrow FeeFailure to DeliverTrendsNewsMore
open chart   
open chart   
Market Cap
3.746M
CEO
Pnina Fishman
Headquarters
P O Box 7537, Petah Tikva, Israel
Industry
Biotechnology
Last Split
2023-01-091for10reverse
Related
MNTAMLNTXLV
CANF Stats
Avg. Vol. 10 Day
22,811
Avg. Vol. 30 Day
61,718
Market Cap
3,745,597
Shares Out.
1,541,398
On/Off Exchange
45%/55%
6 Month Beta
0.62
1 Year Beta
0.61
2 Year Beta
0.45
3 Year Beta
0.49
52 Week Low
1.52
52 Week High
11.20
SMA50
1.98
SMA200
4.29
1 Week
+2.53%
1 Month
+38.86%
3 Month
-10.00%
6 Month
-71.07%
1 Year
-74.14%
2 Year
-88.59%
5 Year
-98.75%
Jan 31, 2022
07:07AM EST  Can Fite Says First Patient Enrolled In Phase IIb NASH Clinical Trial With Namodenoson   RTTNews
07:06AM EST  Can Fite Announces First Patient Enrolled In Phase IIb NASH Clinical Trial With Namodenoson   Benzinga
Jan 21, 2022
11:40AM EST  CanFite Shares Quiet Following US National Institutes Of Health ClinicalTrials.gov Listing For Co.'s 'Namodenoson in the Treatment of Advanced Hepatocellular Carcinoma in Patients With Child-Pugh Class B7 Cirrhosis'   Benzinga
Jan 14, 2022
04:48PM EST  Can-Fite Files For Offering Of Up To 190.5M Shares   Benzinga
Jan 13, 2022
11:47AM EST  The Daily Biotech Pulse: Adagio's Antibody Effective Against Omicron, Sarepta Terminates Gene Therapy Deal, AstraZeneca Inks Oncology Pact   Benzinga
More News
Profile
Can Fite Biofarma Ltd is a clinical stage biopharmaceutical company. It develops orally bioavailable small molecule therapeutic products for the treatment of autoimmune-inflammatory, oncological and ophthalmic diseases.

CANF Stock Summary

Can-Fite Biopharma Ltd - ADR (NYSEAMERICAN:CANF) stock price today is $2.43, and today's volume is 0. CANF is up 8.482% today. The 30 day average volume is 61,718. CANF market cap is 3.746M with 1,541,398 shares outstanding.



Share
About
Symbol List

Pricing
Disclaimer

ChartExchange on Twitter
ChartExchange on Reddit
© 2020 - 2023 ChartExchange LLC